{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:59:12Z","timestamp":1789610352315,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PCa) patients with bone metastasis commonly exhibit osteoblastic-type and have an extremely poor prognosis. Exosomes derived from tumor cells possess biological significance and can mediate intercellular communication in the tumor microenvironment. Long noncoding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) is implicated in tumorigenesis and the development of PCa, but the precise roles of SNHG1 in the regulation of bone homeostasis remain elusive. Herein, we aimed to investigate the underlying mechanisms by which exosomes-encapsulated SNHG1 affects the bone metastasis of PCa. Our findings revealed that SNHG1 was overexpressed in PCa tissues, highly enriched in PCa cell-derived exosomes, and positively correlated with bone metastasis. Besides, SNHG1 shuttled by PCa-derived exosomes could be transferred into osteoblast cells, where SNHG1 exerted inductive properties in osteogenic differentiation. Gain- and loss-of-functional experiments demonstrated that exosomal SNHG1 facilitated the activity of alkaline phosphatase and mineralization of extracellular matrix. Moreover, in vivo experimentation showed that knockdown of exosomal SNHG1 suppressed bone metastasis of PCa cells. Mechanistic investigations revealed that exosomal SNHG1, transmitted to osteoblast cells, physically binds to YBX1 and leads to the shift of YBX1 into the nucleus, then enhances MMP16 transcription and increases the amount of protein translation, ultimately resulting in PCa bone metastasis. In conclusion, our data highlight that PCa-derived exosomes-loaded SNHG1 mediated osteogenesis through the SNHG1\/YBX1\/MMP16 axis. SNHG1 may serve as a potential diagnostic marker and therapeutic target for bone metastasis in PCa.<\/jats:p>","DOI":"10.1038\/s41420-025-02855-5","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:29:29Z","timestamp":1767882569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exosome-transmitted long noncoding RNA SNHG1 promotes prostate cancer bone metastasis via YBX1\/MMP16 axis"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1827-2552","authenticated-orcid":false,"given":"Taowei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zining","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xumin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4938-0177","authenticated-orcid":false,"given":"Shengren","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3794-641X","authenticated-orcid":false,"given":"Jianming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7585-8210","authenticated-orcid":false,"given":"Anyang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-9647","authenticated-orcid":false,"given":"Daojun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7039-0874","authenticated-orcid":false,"given":"Xiangming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"2855_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2855_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, et al. Prostate cancer. Nat Rev Dis Prim. 2021;7:9.","journal-title":"Nat Rev Dis Prim"},{"key":"2855_CR3","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2855_CR4","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1989;8:98\u2013101.","journal-title":"Cancer Metastasis Rev"},{"key":"2855_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","volume":"39","author":"X Zhang","year":"2019","unstructured":"Zhang X. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer. Cancer Commun Lond Engl. 2019;39:76.","journal-title":"Cancer Commun Lond Engl"},{"key":"2855_CR6","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/jbmr.3618","volume":"33","author":"J Fornetti","year":"2018","unstructured":"Fornetti J, Welm AL, Stewart SA. Understanding the bone in cancer metastasis. J Bone Min Res J Am Soc Bone Min Res. 2018;33:2099\u2013113.","journal-title":"J Bone Min Res J Am Soc Bone Min Res"},{"key":"2855_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487\u2013514.","journal-title":"Annu Rev Biochem"},{"key":"2855_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-014-1710-4","volume":"72","author":"SN Saleem","year":"2015","unstructured":"Saleem SN, Abdel-Mageed AB. Tumor-derived exosomes in oncogenic reprogramming and cancer progression. Cell Mol Life Sci. 2015;72:1\u201310.","journal-title":"Cell Mol Life Sci"},{"key":"2855_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Mark MT, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335.","journal-title":"Nature"},{"key":"2855_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/1759-7714.13256","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Zheng H. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p\/FRAT1 axis. Thorac Cancer. 2020;11:295\u2013304.","journal-title":"Thorac Cancer"},{"key":"2855_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bbrc.2017.11.012","volume":"495","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Jiang C, Fang J. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B\/Wnt\/\u03b2-catenin pathway. Biochem Biophys Res Commun. 2018;495:238\u201345.","journal-title":"Biochem Biophys Res Commun"},{"key":"2855_CR12","first-page":"1157","volume":"43","author":"R Deng","year":"2019","unstructured":"Deng R, Zhang J, Chen J. lncRNA SNHG1 negatively regulates miRNA\u2011101\u20113p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma. Int J Mol Med. 2019;43:1157\u201366.","journal-title":"Int J Mol Med"},{"key":"2855_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03031-6","volume":"11","author":"B Li","year":"2020","unstructured":"Li B, Li A, You Z, Xu J, Zhu S. Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma. Cell Death Dis. 2020;11:823.","journal-title":"Cell Death Dis"},{"key":"2855_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.tranon.2018.07.016","volume":"11","author":"Y Lin","year":"2018","unstructured":"Lin Y, Leng Q, Zhan M, Jiang F. A plasma long noncoding RNA signature for early detection of lung cancer. Transl Oncol. 2018;11:1225\u201331.","journal-title":"Transl Oncol"},{"key":"2855_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1373\/clinchem.2018.301150","volume":"65","author":"C Tan","year":"2019","unstructured":"Tan C, Cao J, Chen L, Xi X, Wang S, Zhu Y, et al. Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma. Clin Chem. 2019;65:905\u201315.","journal-title":"Clin Chem"},{"key":"2855_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03413-4","volume":"12","author":"X Tan","year":"2021","unstructured":"Tan X, Chen W-B, Lv D-J, Yang T-W, Wu K-H, Zou L-B, et al. LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer. Cell Death Dis. 2021;12:138.","journal-title":"Cell Death Dis"},{"key":"2855_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.493","volume":"11","author":"C Mo","year":"2021","unstructured":"Mo C, Huang B, Zhuang J, Jiang S, Guo S, Mao X. LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p\/runt-related transcription factor 2\/splicing factor proline- and glutamine-rich\/polypyrimidine tract-binding protein 2 axis. Clin Transl Med. 2021;11:e493.","journal-title":"Clin Transl Med"},{"key":"2855_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.","journal-title":"J Extracell Vesicles"},{"key":"2855_CR19","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41388-018-0540-5","volume":"38","author":"C Probert","year":"2019","unstructured":"Probert C, Dottorini T, Speakman A, Hunt S, Nafee T, Fazeli A, et al. Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis. Oncogene. 2019;38:1751\u201363.","journal-title":"Oncogene"},{"key":"2855_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452\u201363.","journal-title":"Cancer Cell"},{"key":"2855_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejcb.2018.02.003","volume":"97","author":"PS Suresh","year":"2018","unstructured":"Suresh PS, Tsutsumi R, Venkatesh T. YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling. Eur J Cell Biol. 2018;97:163\u20137.","journal-title":"Eur J Cell Biol"},{"key":"2855_CR22","doi-asserted-by":"publisher","first-page":"28562","DOI":"10.1074\/jbc.M100311200","volume":"276","author":"U Stein","year":"2001","unstructured":"Stein U, J\u00fcrchott K, Walther W, Bergmann S, Schlag PM, Royer HD. Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J Biol Chem. 2001;276:28562\u20139.","journal-title":"J Biol Chem"},{"key":"2855_CR23","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1038\/onc.2011.617","volume":"31","author":"A Astanehe","year":"2012","unstructured":"Astanehe A, Finkbeiner MR, Krzywinski M, Fotovati A, Dhillon J, Berquin IM, et al. MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition. Oncogene. 2012;31:4434\u201346.","journal-title":"Oncogene"},{"key":"2855_CR24","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/onc.2008.485","volume":"28","author":"MR Finkbeiner","year":"2009","unstructured":"Finkbeiner MR, Astanehe A, To K, Fotovati A, Davies AH, Zhao Y, et al. Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells. Oncogene. 2009;28:1421\u201331.","journal-title":"Oncogene"},{"key":"2855_CR25","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci USA. 2019;116:11428\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2855_CR26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu Y-M, Schultz N, Lonigro RJ, Mosquera J-M, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161:1215\u201328.","journal-title":"Cell"},{"key":"2855_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05366-3","volume":"9","author":"T Kuchimaru","year":"2018","unstructured":"Kuchimaru T, Kataoka N, Nakagawa K, Isozaki T, Miyabara H, Minegishi M, et al. A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries. Nat Commun. 2018;9:2981.","journal-title":"Nat Commun"},{"key":"2855_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11914-016-0315-2","volume":"14","author":"D Buenrostro","year":"2016","unstructured":"Buenrostro D, Mulcrone PL, Owens P, Sterling JA. The bone microenvironment: a fertile soil for tumor growth. Curr Osteoporos Rep. 2016;14:151\u20138.","journal-title":"Curr Osteoporos Rep"},{"key":"2855_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trecan.2018.12.004","volume":"5","author":"W Zhang","year":"2019","unstructured":"Zhang W, Bado I, Wang H, Lo H-C, Zhang XH-F. Bone metastasis: find your niche and fit in. Trends Cancer. 2019;5:95\u2013110.","journal-title":"Trends Cancer"},{"key":"2855_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ncb3464","volume":"19","author":"C Li","year":"2017","unstructured":"Li C, Wang S, Xing Z, Lin A, Liang K, Song J, et al. A ROR1-HER3-LncRNA signaling axis modulates the Hippo-YAP pathway to regulate bone metastasis. Nat Cell Biol. 2017;19:106\u201319.","journal-title":"Nat Cell Biol"},{"key":"2855_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01293-4","volume":"19","author":"S Wen","year":"2020","unstructured":"Wen S, Wei Y, Zen C, Xiong W, Niu Y, Zhao Y. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. Mol Cancer. 2020;19:171.","journal-title":"Mol Cancer"},{"key":"2855_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cca.2019.03.002","volume":"494","author":"KZ Thin","year":"2019","unstructured":"Thin KZ, Tu JC, Raveendran S. Long non-coding SNHG1 in cancer. Clin Chim Acta Int J Clin Chem. 2019;494:38\u201347.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"2855_CR33","first-page":"77","volume":"52","author":"J Wang","year":"2018","unstructured":"Wang J, Cao L, Wu J, Wang Q. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma. Int J Oncol. 2018;52:77\u201388.","journal-title":"Int J Oncol"},{"key":"2855_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/CAD.0000000000000916","volume":"32","author":"G Huang","year":"2021","unstructured":"Huang G, Guo X, Yang H. Long noncoding RNA SNHG1 promotes human prostate cancer progression by sponging miR-383-5p. Anticancer Drugs. 2021;32:286\u201395.","journal-title":"Anticancer Drugs"},{"key":"2855_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.552907","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Wang F, Xu H, Xu L, Chen D, Wang J, et al. Long non-coding RNA SNHG1 regulates the Wnt\/\u03b2-catenin and PI3K\/AKT\/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell. Front Oncol. 2020;10:552907.","journal-title":"Front Oncol"},{"key":"2855_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4103\/IJPM.IJPM_612_19","volume":"63","author":"Q Tang","year":"2020","unstructured":"Tang Q, Li Z, Han W, Cheng S, Wang Y. High expression of lncRNA SNHG1 in prostate cancer patients and inhibition of SNHG1 suppresses cell proliferation and promotes apoptosis. Indian J Pathol Microbiol. 2020;63:575\u201380.","journal-title":"Indian J Pathol Microbiol"},{"key":"2855_CR37","first-page":"9880","volume":"24","author":"X-F Meng","year":"2020","unstructured":"Meng X-F, Liu A-D, Li S-L. SNHG1 promotes proliferation, invasion and EMT of prostate cancer cells through miR-195-5p. Eur Rev Med Pharm Sci. 2020;24:9880\u20138.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"2855_CR38","first-page":"109","volume":"35","author":"M Xie","year":"2020","unstructured":"Xie M, Zhang Z, Cui Y. Long noncoding RNA SNHG1 contributes to the promotion of prostate cancer cells through regulating miR-377-3p\/AKT2 axis. Cancer Biother Radiopharm. 2020;35:109\u201319.","journal-title":"Cancer Biother Radiopharm"},{"key":"2855_CR39","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.3390\/ijms22073528","volume":"22","author":"T Akoto","year":"2021","unstructured":"Akoto T, Saini S. Role of exosomes in prostate cancer metastasis. Int J Mol Sci. 2021;22:3528.","journal-title":"Int J Mol Sci"},{"key":"2855_CR40","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1084\/jem.20190158","volume":"216","author":"J Dai","year":"2019","unstructured":"Dai J, Escara-Wilke J, Keller JM, Jung Y, Taichman RS, Pienta KJ, et al. Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis. J Exp Med. 2019;216:2883\u201399.","journal-title":"J Exp Med"},{"key":"2855_CR41","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1073\/pnas.1717363115","volume":"115","author":"K Hashimoto","year":"2018","unstructured":"Hashimoto K, Ochi H, Sunamura S, Kosaka N, Mabuchi Y, Fukuda T, et al. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A. Proc Natl Acad Sci USA. 2018;115:2204\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2855_CR42","first-page":"4463","volume":"17","author":"S-L Li","year":"2019","unstructured":"Li S-L, An N, Liu B, Wang S-Y, Wang J-J, Ye Y. Exosomes from LNCaP cells promote osteoblast activity through miR-375 transfer. Oncol Lett. 2019;17:4463\u201373.","journal-title":"Oncol Lett"},{"key":"2855_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","volume":"5","author":"J Dai","year":"2020","unstructured":"Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct Target Ther. 2020;5:145.","journal-title":"Signal Transduct Target Ther"},{"key":"2855_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CMAR.S327621","volume":"14","author":"G Dai","year":"2022","unstructured":"Dai G, Yang Y, Liu S, Liu H. Hypoxic breast cancer cell-derived exosomal SNHG1 promotes breast cancer growth and angiogenesis via regulating miR-216b-5p\/JAK2 Axis. Cancer Manag Res. 2022;14:123\u201333.","journal-title":"Cancer Manag Res"},{"key":"2855_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-021-02209-w","volume":"41","author":"Z Wang","year":"2022","unstructured":"Wang Z, He J, Bach D-H, Huang Y-H, Li Z, Liu H, et al. Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance. J Exp Clin Cancer Res. 2022;41:4.","journal-title":"J Exp Clin Cancer Res"},{"key":"2855_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/wrna.1200","volume":"5","author":"DN Lyabin","year":"2014","unstructured":"Lyabin DN, Eliseeva IA, Ovchinnikov LP. YB-1 protein: functions and regulation. Wiley Interdiscip Rev RNA. 2014;5:95\u2013110.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2855_CR47","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen X, Li A, Sun B-F, Yang Y, Han Y-N, Yuan X, et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019;21:978\u201390.","journal-title":"Nat Cell Biol"},{"key":"2855_CR48","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.biochi.2020.10.004","volume":"179","author":"F Sangermano","year":"2020","unstructured":"Sangermano F, Delicato A, Calabr\u00f2 V. Y box binding protein 1 (YB-1) oncoprotein at the hub of DNA proliferation, damage and cancer progression. Biochimie. 2020;179:205\u201316.","journal-title":"Biochimie"},{"key":"2855_CR49","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0014-5793(97)01296-9","volume":"417","author":"K Koike","year":"1997","unstructured":"Koike K, Uchiumi T, Ohga T, Toh S, Wada M, Kohno K, et al. Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett. 1997;417:390\u20134.","journal-title":"FEBS Lett"},{"key":"2855_CR50","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1432-1033.2003.03968.x","volume":"271","author":"LS Coles","year":"2004","unstructured":"Coles LS, Bartley MA, Bert A, Hunter J, Polyak S, Diamond P, et al. A multi-protein complex containing cold shock domain (Y-box) and polypyrimidine tract binding proteins forms on the vascular endothelial growth factor mRNA. Eur J Biochem. 2004;271:648\u201360.","journal-title":"Eur J Biochem"},{"key":"2855_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1767","volume":"9","author":"AL Stratford","year":"2007","unstructured":"Stratford AL, Habibi G, Astanehe A, Jiang H, Hu K, Park E, et al. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy. Breast Cancer Res. 2007;9:R61.","journal-title":"Breast Cancer Res"},{"key":"2855_CR52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/1535-7163.MCT-12-1125","volume":"12","author":"T Shibata","year":"2013","unstructured":"Shibata T, Kan H, Murakami Y, Ureshino H, Watari K, Kawahara A, et al. Y-box binding protein-1 contributes to both HER2\/ErbB2 expression and lapatinib sensitivity in human gastric cancer cells. Mol Cancer Ther. 2013;12:737\u201346.","journal-title":"Mol Cancer Ther"},{"key":"2855_CR53","doi-asserted-by":"publisher","first-page":"22905","DOI":"10.1074\/jbc.272.36.22905","volume":"272","author":"PR Mertens","year":"1997","unstructured":"Mertens PR, Harendza S, Pollock AS, Lovett DH. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1*. J Biol Chem. 1997;272:22905\u201312.","journal-title":"J Biol Chem"},{"key":"2855_CR54","doi-asserted-by":"publisher","first-page":"E224","DOI":"10.3390\/ijms22010224","volume":"22","author":"L-Z Liao","year":"2020","unstructured":"Liao L-Z, Chen C-T, Li N-C, Lin L-C, Huang B-S, Chang Y-H, et al. Y-box binding protein-1 promotes epithelial-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells. Int J Mol Sci. 2020;22:E224.","journal-title":"Int J Mol Sci"},{"key":"2855_CR55","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbrc.2010.06.104","volume":"398","author":"DH Lovett","year":"2010","unstructured":"Lovett DH, Cheng S, Cape L, Pollock AS, Mertens PR. YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis. Biochem Biophys Res Commun. 2010;398:482\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"2855_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jbo.2017.01.002","volume":"6","author":"AR Ferreira","year":"2017","unstructured":"Ferreira AR, Bettencourt M, Alho I, Costa AL, Sousa AR, Mansinho A, et al. Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases. J Bone Oncol. 2017;6:16\u201321.","journal-title":"J Bone Oncol"},{"key":"2855_CR57","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-11-0017","volume":"18","author":"M Shiota","year":"2011","unstructured":"Shiota M, Takeuchi A, Song Y, Yokomizo A, Kashiwagi E, Uchiumi T, et al. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression. Endocr Relat Cancer. 2011;18:505\u201317.","journal-title":"Endocr Relat Cancer"},{"key":"2855_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02279-x","volume":"7","author":"A Heumann","year":"2017","unstructured":"Heumann A, Kaya \u00d6, Burdelski C, Hube-Magg C, Kluth M, Lang DS, et al. Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer. Sci Rep. 2017;7:2056.","journal-title":"Sci Rep"},{"key":"2855_CR59","doi-asserted-by":"publisher","unstructured":"Shiota M, Fujimoto N, Imada K, Yokomizo A, Itsumi M, Takeuchi A, et al. Potential role for YB-1 in castration-resistant prostate cancer and resistance to enzalutamide through the androgen receptor V7. J Natl Cancer Inst 2016;108. https:\/\/doi.org\/10.1093\/jnci\/djw005.","DOI":"10.1093\/jnci\/djw005"},{"key":"2855_CR60","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1093\/nar\/gkaa127","volume":"48","author":"X Wang","year":"2020","unstructured":"Wang X, Zhang X, Dang Y, Li D, Lu G, Chan W-Y, et al. Long noncoding RNA HCP5 participates in premature ovarian insufficiency by transcriptionally regulating MSH5 and DNA damage repair via YB1. Nucleic Acids Res. 2020;48:4480\u201391.","journal-title":"Nucleic Acids Res"},{"key":"2855_CR61","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.omtn.2020.10.025","volume":"22","author":"W Su","year":"2020","unstructured":"Su W, Wang L, Zhao H, Hu S, Zhou Y, Guo C, et al. LINC00857 interacting with YBX1 to regulate apoptosis and autophagy via MET and phosphor-AMPKa signaling. Mol Ther Nucleic Acids. 2020;22:1164\u201375.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2855_CR62","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/s41388-018-0382-1","volume":"37","author":"S-J Deng","year":"2018","unstructured":"Deng S-J, Chen H-Y, Ye Z, Deng S-C, Zhu S, Zeng Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37:5811\u201328.","journal-title":"Oncogene"},{"key":"2855_CR63","first-page":"406","volume":"18","author":"T-W Yang","year":"2019","unstructured":"Yang T-W, Sahu D, Chang Y-W, Hsu C-L, Hsieh C-H, Huang H-C, et al. RNA-binding proteomics reveals MATR3 interacting with lncRNA SNHG1 to enhance neuroblastoma progression. J Proteome Res. 2019;18:406\u201316.","journal-title":"J Proteome Res"},{"key":"2855_CR64","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52\u201367.","journal-title":"Cell"},{"key":"2855_CR65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.abb.2014.07.034","volume":"561","author":"KBS Paiva","year":"2014","unstructured":"Paiva KBS, Granjeiro JM. Bone tissue remodeling and development: focus on matrix metalloproteinase functions. Arch Biochem Biophys. 2014;561:74\u201387.","journal-title":"Arch Biochem Biophys"},{"key":"2855_CR66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.pmbts.2017.05.001","volume":"148","author":"KBS Paiva","year":"2017","unstructured":"Paiva KBS, Granjeiro JM. Matrix metalloproteinases in bone resorption, remodeling, and repair. Prog Mol Biol Transl Sci. 2017;148:203\u2013303.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2855_CR67","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ydbio.2007.10.017","volume":"313","author":"J Shi","year":"2008","unstructured":"Shi J, Son M-Y, Yamada S, Szabova L, Kahan S, Chrysovergis K, et al. Membrane-type MMPs enable extracellular matrix permissiveness and mesenchymal cell proliferation during embryogenesis. Dev Biol. 2008;313:196\u2013209.","journal-title":"Dev Biol"},{"key":"2855_CR68","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1159\/000438575","volume":"37","author":"B Chen","year":"2015","unstructured":"Chen B, Huang Z, Zhang Y, Chen Y, Li Z. MicroRNA-145 suppresses osteosarcoma metastasis via targeting MMP16. Cell Physiol Biochem. 2015;37:2183\u201393.","journal-title":"Cell Physiol Biochem"},{"key":"2855_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0829-7","volume":"19","author":"J Shi","year":"2019","unstructured":"Shi J, An G, Guan Y, Wei T, Peng Z, Liang M, et al. miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16. Cancer Cell Int. 2019;19:104.","journal-title":"Cancer Cell Int"},{"key":"2855_CR70","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.3892\/ol.2017.6536","volume":"14","author":"C Jiang","year":"2017","unstructured":"Jiang C, Wang J, Dong C, Wei W, Li J, Li X. Membranous type matrix metalloproteinase 16 induces human prostate cancer metastasis. Oncol Lett. 2017;14:3096\u2013102.","journal-title":"Oncol Lett"},{"key":"2855_CR71","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41585-018-0020-2","volume":"15","author":"RB Berish","year":"2018","unstructured":"Berish RB, Ali AN, Telmer PG, Ronald JA, Leong HS. Translational models of prostate cancer bone metastasis. Nat Rev Urol. 2018;15:403\u201321.","journal-title":"Nat Rev Urol"},{"key":"2855_CR72","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10585-019-09999-6","volume":"36","author":"R Fujita","year":"2019","unstructured":"Fujita R, Hamano H, Kameda Y, Arai R, Shimizu T, Ota M, et al. Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization. Clin Exp Metastasis. 2019;36:539\u201349.","journal-title":"Clin Exp Metastasis"},{"key":"2855_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.353","volume":"11","author":"D Gong","year":"2021","unstructured":"Gong D, Sun Y, Guo C, Sheu T-J, Zhai W, Zheng J, et al. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis. Clin Transl Med. 2021;11:e353.","journal-title":"Clin Transl Med"},{"key":"2855_CR74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-0716-1258-3_4","volume":"2274","author":"T Kuchimaru","year":"2021","unstructured":"Kuchimaru T, Kizaka-Kondoh S. A murine bone metastasis model using caudal artery injection and bioluminescence imaging. Methods Mol Biol Clifton NJ. 2021;2274:37\u201342.","journal-title":"Methods Mol Biol Clifton NJ"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02855-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02855-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T15:04:54Z","timestamp":1767884694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02855-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2855"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02855-5","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental methods were conducted in accordance with relevant guidelines and regulations. Studies involving human samples were approved by the Ethics Committee of Zhujiang Hospital, Southern Medical University. Informed consent was obtained from all subjects. The animal work was approved by the Laboratory Animal Ethics Committee of ZhuJiang Hospital of SMU (no. SYXK-2019-0215).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"7"}}